LCMV gp33-41 (TFA) (151705-84-9 free base)
CAS No. ——
LCMV gp33-41 (TFA) (151705-84-9 free base)( —— )
Catalog No. M30328 CAS No. ——
LCMV gp33-41 (TFA), the carboxyl-extended 11-aa-long peptide, is an lymphocytic choriomeningitis virus sequence restricted by MHC class I H-2Db molecules and presented to cytotoxic T lymphocytes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLCMV gp33-41 (TFA) (151705-84-9 free base)
-
NoteResearch use only, not for human use.
-
Brief DescriptionLCMV gp33-41 (TFA), the carboxyl-extended 11-aa-long peptide, is an lymphocytic choriomeningitis virus sequence restricted by MHC class I H-2Db molecules and presented to cytotoxic T lymphocytes.
-
DescriptionLCMV gp33-41 (TFA), the carboxyl-extended 11-aa-long peptide, is an lymphocytic choriomeningitis virus sequence restricted by MHC class I H-2Db molecules and presented to cytotoxic T lymphocytes.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight1158.24
-
Molecular FormulaC50H74N11F3015S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:Lys-Ala-Val-Tyr-Asn-Phe-Ala-Thr-Met
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Gairin JE, et al. Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes. J Virol. 1995 Apr;69(4):2297-305.
molnova catalog
related products
-
Kisspeptin-10, rat
Endogenous ligand for the rodent kisspeptin receptor (KISS1, GPR54).
-
2-Methoxyethanol
2-Methoxyethanol is used in the synthesis of 2-aminothiazoles in the treatment of prion disease. 2-Methoxyethanol is also used in the preparation of Rho-associated kinase inhibitors or (ROCK) inhibitors for the treatment of cardiovascular disease.
-
β-Amyloid Protein Pr...
β-Amyloid Protein Precursor (657 - 676)
Cart
sales@molnova.com